Log in
Enquire now

List of Visterra Inc. patents

List of Visterra Inc. patents
List of Quantum Machines patents
List of KenCast patents
List of Quantifind patents
List of SBIR/STTR awards granted to Product Innovation And Engineering, LLC
List of companies in Triputra Group's investment portfolio
Patents where
Current Assignee
Name
is
‌
Visterra Inc.
Name
Description
Patent Applicant
Current Assignee
Inventor
Patent Jurisdiction
Patent Number
Date of Patent
‌
US Patent 9365639 Antibody molecules to dengue virus and uses thereof

Patent 9365639 was granted and assigned to Visterra Inc. on June, 2016 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9365639
June 14, 2016
‌
US Patent 9212217 Antibody molecules to dengue virus and uses thereof

Patent 9212217 was granted and assigned to Visterra Inc. on December, 2015 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9212217
December 15, 2015
‌
US Patent 9969794 HA binding agents

Patent 9969794 was granted and assigned to Visterra Inc. on May, 2018 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9969794
May 15, 2018
‌
US Patent 9096657 HA binding agents

Patent 9096657 was granted and assigned to Visterra Inc. on August, 2015 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9096657
August 4, 2015
‌
US Patent 8877200 HA binding agents

Patent 8877200 was granted and assigned to Visterra Inc. on November, 2014 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
8877200
November 4, 2014
‌
US Patent 9447133 Synthetic oligosaccharides for moraxella vaccine

Patent 9447133 was granted and assigned to Visterra Inc. on September, 2016 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
9447133
September 20, 2016
‌
US Patent 11945868 Antibody molecules to CD138 and uses thereof

Patent 11945868 was granted and assigned to Visterra Inc. on April, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11945868
April 2, 2024
‌
US Patent 11969476 Antibody molecule-drug conjugates and uses thereof

Patent 11969476 was granted and assigned to Visterra Inc. on April, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11969476
April 30, 2024
‌
US Patent 11773179 Antibody molecules to C5aR1 and uses thereof

Patent 11773179 was granted and assigned to Visterra Inc. on October, 2023 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11773179
October 3, 2023
‌
US Patent 11858980 Engineered polypeptides and uses thereof

Patent 11858980 was granted and assigned to Visterra Inc. on January, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11858980
January 2, 2024
‌
US Patent 11912781 Humanized complement 5A receptor 1 antibodies and methods of use thereof

Patent 11912781 was granted and assigned to Visterra Inc. on February, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11912781
February 27, 2024
‌
US Patent 11918651 Formulations of antibody molecules to dengue virus

Patent 11918651 was granted and assigned to Visterra Inc. on March, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11918651
March 5, 2024
‌
US Patent 12084484 Interleukin-2 agents and uses thereof

Patent 12084484 was granted and assigned to Visterra Inc. on September, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
12084484
September 10, 2024
‌
US Patent 11890319 Antibody molecule-drug conjugates and uses thereof

Patent 11890319 was granted and assigned to Visterra Inc. on February, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
11890319
February 6, 2024
‌
US Patent 12024552 Ha binding agents

Patent 12024552 was granted and assigned to Visterra Inc. on July, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
12024552
July 2, 2024
‌
US Patent 12091451 Method of using antibody molecules to detect a proliferation-inducing ligand (APRIL)

Patent 12091451 was granted and assigned to Visterra Inc. on September, 2024 by the United States Patent and Trademark Office.

‌
Visterra Inc.
‌
Visterra Inc.
United States Patent and Trademark Office
United States Patent and Trademark Office
12091451
September 17, 2024
16 results
0 selected
16 results
0 selected
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us